Literature DB >> 25440570

Consensus statements on adherence issues in schizophrenia for Hong Kong.

K Y Mak1, W T L Lo2, W S Yeung3, Michael Wong4, W S D Chung5, E Chui4, Ka-Lok Tam6, L K Hui7, Jolene Mui8, O W Chan9, K L Wong4.   

Abstract

AIM: In view of the clinical importance of the adherence issues in schizophrenia management, a consensus group of experienced local psychiatrists and nurse specialists gathered to outline a number of consensus statements for clinicians to consider enhancing adherence in their patients. PROCESS: Prior to the consensus group meeting, three core members drafted eight statements on the issue of adherence in schizophrenia. Using a modified Delphi method, published literature and published guidelines regarding the management of schizophrenia were reviewed by the full panel during the group meeting. After discussion and reflection from each individual member of the consensus group, the eight statements were reworded and electronically voted on anonymously in two steps: acceptance on quality of evidence and practicability in implementation.
RESULTS: After modifications of the original statements, there was very high overall level of agreement and acceptance (reaching international standard) on all the five areas of adherence within the eight statements of the finalised statement.
CONCLUSIONS: The present consensus statements are the first in Hong Kong to address systematically adherence issues in schizophrenia management. They include areas on adherence assessment and definition, treatment strategies in enhancing adherence, and treatment considerations at specific phases of schizophrenia. They are tailored to be of practical utility in the local Hong Kong setting.
Copyright © 2014 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adherence; Consensus statements; Hong Kong; Schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 25440570     DOI: 10.1016/j.ajp.2014.06.018

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  2 in total

Review 1.  Guidance on the clinical understanding and use of long-acting injectable antipsychotics in Schizophrenia: Hong Kong Consensus Statements.

Authors:  Michael Ming Cheuk Wong; Albert Kar Kin Chung; Timothy Ming Hong Yeung; David Tai Wai Wong; Che Kin Lee; Eric Lai; Gloria Fong Yeung Chan; Gregory Kai Lok Mak; Jessica Oi Yin Wong; Roger Man Kin Ng; Ki Yan Mak
Journal:  CNS Neurosci Ther       Date:  2021-03       Impact factor: 5.243

2.  Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence.

Authors:  William Ak-Lam Lo; Daniel Ki-Yan Mak; Michael Ming-Cheuk Wong; Oi-Wah Chan; Eileena Mo-Ching Chui; Dicky Wai-Sau Chung; Glendy Suk-Han Ip; Ka-Shing Lau; Che-Kin Lee; Jolene Mui; Ka-Lok Tam; Samson Tse; Kwong-Lui Wong
Journal:  CNS Neurosci Ther       Date:  2021-03       Impact factor: 5.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.